The metabolic score for insulin resistance (METS-IR) is a recently developed
parameter for screening of metabolic disorder. However, the association between
METS-IR and risk of hypertension in general adult population remains not fully
determined. A meta-analysis was therefore performed. Observational studies
evaluating the association between METS-IR and hypertension in adults were
retrieved by searching PubMed, Embase, and Web of Science databases from
inception to October 10, 2022. A random-effects model, which incorporates the
potential influence of heterogeneity, was used to pool the results. Eight
studies with 305 341 adults were included in the meta-analysis, and 47 887
(15.7%) of them had hypertension. Pooled results showed that a higher
METS-IR was associated with hypertension after adjusting for multiple
conventional risk factors [relative risk (RR) for highest versus lowest category
of METS-IR: 1.67, 95% confidence interval (CI): 1.53 to 1.83,
p<0.001, I2=8%]. The results were consistent in subgroup
analyses according to study design, source of the cohort, age, sex, body mass
index of the participants, and quality scores of the study (p for subgroup
difference all>0.05). Results of meta-analysis with METS-IR analyzed in
continuous variables also showed that METS-IR was associated with the risk of
hypertension (RR for 1-unit increment of METS-IR: 1.15, 95% CI: 1.08 to
1.23, p<0.001, I2=79%). In conclusion, a high METS-IR is
associated with hypertension in general adult population. Measuring METS-IR may
be useful for screening participants at high risk of hypertension.